Stay Alert for Lybalvi, a New Combo Antipsychotic

January 2022

Lybalvi will be a new Rx for schizophrenia or bipolar disorder.

It combines the antipsychotic olanzapine (Zyprexa) with a new med, samidorphan.

The idea is that samidorphan may lessen weight gain from olanzapine...possibly by blocking receptors that regulate appetite.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Insurance Help Patients Navigate Insurance Changes for 2022
COVID-19 Listen for Questions About Molnupiravir to Treat COVID-19
Ophthalmology Watch for Vuity, an Eye Drop to Improve Near Vision
Supplements Expect Patients to Ask About Turmeric for COVID-19 and Other Uses
High-Alert Meds Put Up Safeguards for New "High-Alert" Meds
Antipsychotics Stay Alert for Lybalvi, a New Combo Antipsychotic
End-of-Life Care Be Familiar With Special Med Considerations at the End of Life
Men's Health Avoid Mishaps With Meds for Benign Prostatic Hyperplasia
E-Cigarettes Know What FDA Authorization of E-Cigarettes Really Means